Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability

A’dem Bokhari , Vincent Jonchere , Anaïs Lagrange , Romane Bertrand , Magali Svrcek , Laetitia Marisa , Olivier Buhard , Malorie Greene , Anastasia Demidova , Jieshuang Jia , Eric Adriaenssens (1) , Thierry Chassat , Denis S Biard , Jean-François Flejou , Fabrice Lejeune , Alex Duval , Ada Collura

1 CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277

Abstract Nonsense-mediated mRNA decay (NMD) is responsible for the degradation of mRNAs with a premature termination codon (PTC). The role of this system in cancer is still quite poorly understood. In the present study, we evaluated the functional consequences of NMD activity in a subgroup of colorectal cancers (CRC) characterized by high levels of mRNAs with a PTC due to widespread instability in microsatellite sequences (MSI). In comparison to microsatellite stable (MSS) CRC, MSI CRC expressed increased levels of two critical activators of the NMD system, UPF1/2 and SMG1/6/7. Suppression of NMD activity led to the re-expression of dozens of PTC mRNAs. Amongst these, several encoded mutant proteins with putative deleterious activity against MSI tumorigenesis (e.g., HSP110DE9 chaperone mutant). Inhibition of NMD in vivo using amlexanox reduced MSI tumor growth, but not that of MSS tumors. These results suggest that inhibition of the oncogenic activity of NMD may be an effective strategy for the personalized treatment of MSI CRC.

Domaines: Sciences du Vivant [q-bio]

A’dem Bokhari, Vincent Jonchere, Anaïs Lagrange, Romane Bertrand, Magali Svrcek, et al.. Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability. Oncogenesis, 2018, 7 (9), pp.70. ⟨10.1038/s41389-018-0079-x⟩. ⟨hal-04488722⟩